In light of the increasing interest in G9a's role in neuroscience, three machine learning (ML) models, that are time efficient and cost effective, were developed to support researchers in this area. The models are based on data provided by PubChem and performed by algorithms interpreted by the scikit-learn Python-based ML library. The first ML model aimed to predict the efficacy magnitude of active G9a inhibitors. The ML models were trained with 3,112 and tested with 778 samples. The Gradient Boosting Regressor perform the best, achieving 17.81% means relative error (MRE), 21.48% mean absolute error (MAE), 27.39% root mean squared error (RMSE) and 0.02 coefficient of determination (R2) error. The goal of the second ML model called a CID_SID ML model, utilised PubChem identifiers to predict the G9a inhibition probability of a small biomolecule that has been primarily designed for different purposes. The ML models were trained with 58,552 samples and tested with 14,000. The most suitable classifier for this case study was the Extreme Gradient Boosting Classifier, which obtained 78.1% accuracy, 84.3% precision,69.1% recall, 75.9% F1-score and 8.1% Receiver-operating characteristic (ROC). The third ML model based on the Random Forest Classifier algorithm led to the generation of a list of descending-ordered functional groups based on their importance to the G9a inhibition. The model was trained with 19,455 samples and tested with 14,100. The probability of this rank was 70% accuracy.